檢索結果 - Ashley M. Hopkins

  • Showing 1 - 18 results of 18
Refine Results
  1. 1
    Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials

    Evaluation of the Lung Immune Prognostic Index for Prediction of Survival and Response in Patients Treated With Atezolizumab for NSCLC: Pooled Analysis of Clinical Trials 由 Michael J. Sorich, Andrew Rowland, Christos S. Karapetis, Ashley M. Hopkins

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift

    Artificial intelligence chatbots will revolutionize how cancer patients access information: ChatGPT represents a paradigm-shift 由 Ashley M. Hopkins, Jessica M. Logan, Ganessan Kichenadasse, Michael J. Sorich

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab

    Concomitant Proton Pump Inhibitor Use and Survival in Urothelial Carcinoma Treated with Atezolizumab 由 Ashley M. Hopkins, Ganessan Kichenadasse, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab

    Development and Validation of a Prognostic Model for Patients with Advanced Lung Cancer Treated with the Immune Checkpoint Inhibitor Atezolizumab 由 Ashley M. Hopkins, Ganessan Kichenadasse, Elizabeth Garrett–Mayer, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    出版 2020
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer

    Association Between Body Mass Index and Overall Survival With Immune Checkpoint Inhibitor Therapy for Advanced Non–Small Cell Lung Cancer 由 Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab

    Multiorgan Immune-Related Adverse Events During Treatment With Atezolizumab 由 Ganessan Kichenadasse, John O. Miners, Arduino A. Mangoni, Andrew Rowland, Ashley M. Hopkins, Michael J. Sorich

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease

    Selective Isolation of Liver-Derived Extracellular Vesicles Redefines Performance of miRNA Biomarkers for Non-Alcoholic Fatty Liver Disease 由 Lauren A. Newman, Zivile Useckaite, Jillian G. Johnson, Michael J. Sorich, Ashley M. Hopkins, Andrew Rowland

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy

    The predictive utility of patient-reported outcomes and performance status for survival in metastatic lung cancer patients treated with chemoimmunotherapy 由 Sarah Badaoui, Adel Shahnam, Ross A. McKinnon, Ahmad Y. Abuhelwa, Michael J. Sorich, Ashley M. Hopkins

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials

    Efficacy of Atezolizumab in Patients With Advanced NSCLC Receiving Concomitant Antibiotic or Proton Pump Inhibitor Treatment: Pooled Analysis of Five Randomized Control Trials 由 Ashley M. Hopkins, Sarah Badaoui, Ganessan Kichenadasse, Christos S. Karapetis, Ross A. McKinnon, Andrew Rowland, Michael J. Sorich

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers

    Predicting response and toxicity to immune checkpoint inhibitors using routinely available blood and clinical markers 由 Ashley M. Hopkins, Andrew Rowland, Ganessan Kichenadasse, Michael D. Wiese, Howard Gurney, Ross A. McKinnon, Christos S. Karapetis, Michael J. Sorich

    出版 2017
    獲取全文 獲取全文
    Revisão
    加到收藏夾
    Saved in:
  11. 11
    Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150

    Efficacy of first-line atezolizumab combination therapy in patients with non-small cell lung cancer receiving proton pump inhibitors: post hoc analysis of IMpower150 由 Ashley M. Hopkins, Ganessan Kichenadasse, Ross A. McKinnon, Ahmad Y. Abuhelwa, Jessica M. Logan, Sarah Badaoui, Christos S. Karapetis, Andrew Rowland, Michael J. Sorich

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis

    Comparative Risk of Gout Flares When Initiating or Escalating Various Urate‐Lowering Therapy: A Systematic Review With Network Meta‐Analysis 由 Dorsa Maher, Emily Reeve, Ashley M. Hopkins, Jiun Ming Tan, Mahsa Tantiongco, Nagham Ailabouni, Richard Woodman, Lisa K. Stamp, David Bursill, Susanna Proudman, Michael D. Wiese

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  13. 13
    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data

    The obesity paradox in early and advanced HER2 positive breast cancer: pooled analysis of clinical trial data 由 Natansh D. Modi, Eugene Tan, Andrew Rowland, Bogda Koczwara, Ahmad Y. Abuhelwa, Ganessan Kichenadasse, Ross A. McKinnon, Michael D. Wiese, Michael J. Sorich, Ashley M. Hopkins

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach

    Tumour Mutational Burden and Immune Checkpoint Inhibitor Response in Non-small Cell Lung Cancer: A Continuous Modelling Approach 由 Michael J. Sorich, Arkady T. Manning‐Bennett, Lee X. Li, Adel Shahnam, Ganessan Kichenadasse, Christos S. Karapetis, Ahmad Y. Abuhelwa, Ross A. McKinnon, Andrew Rowland, Ashley M. Hopkins

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis

    Current safeguards, risk mitigation, and transparency measures of large language models against the generation of health disinformation: repeated cross sectional analysis 由 Bradley D. Menz, Nicole M. Kuderer, Stephen Bacchi, Natansh D. Modi, Benjamin Chin‐Yee, Tiancheng Hu, Ceara Rickard, Mark Haseloff, Agnès Vitry, Ross A. McKinnon, Ganessan Kichenadasse, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models

    Generative AI Chatbots for Reliable Cancer Information: Evaluating web-search, multilingual, and reference capabilities of emerging large language models 由 Bradley D. Menz, Natansh D. Modi, Ahmad Y. Abuhelwa, Warit Ruanglertboon, Agnès Vitry, Yuan Gao, Lee X. Li, Rakchha Chhetri, Benjamin Chu, Stephen Bacchi, Ganessan Kichenadasse, Adel Shahnam, Andrew Rowland, Michael J. Sorich, Ashley M. Hopkins

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system

    Exploring the role of sporadic BRAF and KRAS mutations during colorectal cancer pathogenesis: A spotlight on the contribution of the endosome-lysosome system 由 Jingying Tang, Giang T. Lam, Robert D. Brooks, Mark A. Miles, Zivile Useckaite, I. R. Johnson, Benjamin S.‐Y. Ung, Carmela Martini, Litsa Karageorgos, Shane M. Hickey, Stavros Selemidis, Ashley M. Hopkins, Andrew Rowland, Ryash Vather, John O’Leary, Doug A. Brooks, Maria C. Caruso, Jessica M. Logan

    出版 2024
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  18. 18
    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority trial

    Annual versus less frequent mammographic surveillance in people with breast cancer aged 50 years and older in the UK (Mammo-50): a multicentre, randomised, phase 3, non-inferiority... 由 Janet Dunn, Peter Donnelly, Nada Elbeltagi, Andrea Marshall, Ashley M. Hopkins, Alastair M. Thompson, Riccardo A. Audisio, Sarah E. Pinder, David Cameron, Sue M. Hartup, Lesley Turner, Annie Young, Helen M. Higgins, Eila Watson, Sophie Gasson, Peter Barrett‐Lee, Claire Hulme, Bethany Shinkins, Peter Hall, Andrew Evans

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: